Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH)

Rohit Bhargava, Orit Oppenheimer, William Gerald, Suresh C. Jhanwar, Beiyun Chen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Chromogenic in situ hybridization (CISH) is a recently developed technique, which utilizes the general principles of in situ hybridization and a detection system similar to immunohistochemistry. To assess the utility of CISH for analysis of MYCN gene amplification, we compared this assay with established diagnostic assays such as Southern blot analysis (SB) and fluorescent in situ hybridization (FISH), CISH was performed on 67 cases of neuroblastoma using tissue microarray (65 cases) and whole tissue sections (2 cases), Unequivocal, high-level amplification (≥10 gene copies per tumor nucleus) was identified in 19 of 67 (28,4%) tumors, Two (3%) tumors showed low-level amplification (6-9 gene copies per tumor nucleus). No amplification was seen in 46 of 67 (68.6%) tumors. SB data were available in 44 tumors. Forty-one of the 44 tumors (93%) showed concordant results between CISH and SB. Three tumors showed MYCN amplification by CISH but no amplification by SB, most likely due to dilution effect of nonneoplastic tissue in the test samples. Two of these three tumors also showed MYCN amplification by FISH, and the third tumor was not analyzed by FISH. FISH data were available in total of 30 tumors. All 30 tumors showed concordant results between CISH and FISH for classifying a tumor as MYCN amplified or not amplified. We conclude that CISH is an accurate method for determining MYCN gene amplification, with added advantages that make it a more practically useful method.

Original languageEnglish (US)
Pages (from-to)72-76
Number of pages5
JournalDiagnostic Molecular Pathology
Volume14
Issue number2
DOIs
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Gene Amplification
Neuroblastoma
In Situ Hybridization
Neoplasms
Fluorescence In Situ Hybridization
Southern Blotting
Immunohistochemistry

Keywords

  • Chromogenic in situ hybridization
  • CISH
  • MYCN
  • Neuroblastoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH). / Bhargava, Rohit; Oppenheimer, Orit; Gerald, William; Jhanwar, Suresh C.; Chen, Beiyun.

In: Diagnostic Molecular Pathology, Vol. 14, No. 2, 06.2005, p. 72-76.

Research output: Contribution to journalArticle

Bhargava, Rohit ; Oppenheimer, Orit ; Gerald, William ; Jhanwar, Suresh C. ; Chen, Beiyun. / Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH). In: Diagnostic Molecular Pathology. 2005 ; Vol. 14, No. 2. pp. 72-76.
@article{c975095fa58c4cd6b06d7ddedaa935d4,
title = "Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH)",
abstract = "Chromogenic in situ hybridization (CISH) is a recently developed technique, which utilizes the general principles of in situ hybridization and a detection system similar to immunohistochemistry. To assess the utility of CISH for analysis of MYCN gene amplification, we compared this assay with established diagnostic assays such as Southern blot analysis (SB) and fluorescent in situ hybridization (FISH), CISH was performed on 67 cases of neuroblastoma using tissue microarray (65 cases) and whole tissue sections (2 cases), Unequivocal, high-level amplification (≥10 gene copies per tumor nucleus) was identified in 19 of 67 (28,4{\%}) tumors, Two (3{\%}) tumors showed low-level amplification (6-9 gene copies per tumor nucleus). No amplification was seen in 46 of 67 (68.6{\%}) tumors. SB data were available in 44 tumors. Forty-one of the 44 tumors (93{\%}) showed concordant results between CISH and SB. Three tumors showed MYCN amplification by CISH but no amplification by SB, most likely due to dilution effect of nonneoplastic tissue in the test samples. Two of these three tumors also showed MYCN amplification by FISH, and the third tumor was not analyzed by FISH. FISH data were available in total of 30 tumors. All 30 tumors showed concordant results between CISH and FISH for classifying a tumor as MYCN amplified or not amplified. We conclude that CISH is an accurate method for determining MYCN gene amplification, with added advantages that make it a more practically useful method.",
keywords = "Chromogenic in situ hybridization, CISH, MYCN, Neuroblastoma",
author = "Rohit Bhargava and Orit Oppenheimer and William Gerald and Jhanwar, {Suresh C.} and Beiyun Chen",
year = "2005",
month = "6",
doi = "10.1097/01.pas.0000149878.78117.ff",
language = "English (US)",
volume = "14",
pages = "72--76",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH)

AU - Bhargava, Rohit

AU - Oppenheimer, Orit

AU - Gerald, William

AU - Jhanwar, Suresh C.

AU - Chen, Beiyun

PY - 2005/6

Y1 - 2005/6

N2 - Chromogenic in situ hybridization (CISH) is a recently developed technique, which utilizes the general principles of in situ hybridization and a detection system similar to immunohistochemistry. To assess the utility of CISH for analysis of MYCN gene amplification, we compared this assay with established diagnostic assays such as Southern blot analysis (SB) and fluorescent in situ hybridization (FISH), CISH was performed on 67 cases of neuroblastoma using tissue microarray (65 cases) and whole tissue sections (2 cases), Unequivocal, high-level amplification (≥10 gene copies per tumor nucleus) was identified in 19 of 67 (28,4%) tumors, Two (3%) tumors showed low-level amplification (6-9 gene copies per tumor nucleus). No amplification was seen in 46 of 67 (68.6%) tumors. SB data were available in 44 tumors. Forty-one of the 44 tumors (93%) showed concordant results between CISH and SB. Three tumors showed MYCN amplification by CISH but no amplification by SB, most likely due to dilution effect of nonneoplastic tissue in the test samples. Two of these three tumors also showed MYCN amplification by FISH, and the third tumor was not analyzed by FISH. FISH data were available in total of 30 tumors. All 30 tumors showed concordant results between CISH and FISH for classifying a tumor as MYCN amplified or not amplified. We conclude that CISH is an accurate method for determining MYCN gene amplification, with added advantages that make it a more practically useful method.

AB - Chromogenic in situ hybridization (CISH) is a recently developed technique, which utilizes the general principles of in situ hybridization and a detection system similar to immunohistochemistry. To assess the utility of CISH for analysis of MYCN gene amplification, we compared this assay with established diagnostic assays such as Southern blot analysis (SB) and fluorescent in situ hybridization (FISH), CISH was performed on 67 cases of neuroblastoma using tissue microarray (65 cases) and whole tissue sections (2 cases), Unequivocal, high-level amplification (≥10 gene copies per tumor nucleus) was identified in 19 of 67 (28,4%) tumors, Two (3%) tumors showed low-level amplification (6-9 gene copies per tumor nucleus). No amplification was seen in 46 of 67 (68.6%) tumors. SB data were available in 44 tumors. Forty-one of the 44 tumors (93%) showed concordant results between CISH and SB. Three tumors showed MYCN amplification by CISH but no amplification by SB, most likely due to dilution effect of nonneoplastic tissue in the test samples. Two of these three tumors also showed MYCN amplification by FISH, and the third tumor was not analyzed by FISH. FISH data were available in total of 30 tumors. All 30 tumors showed concordant results between CISH and FISH for classifying a tumor as MYCN amplified or not amplified. We conclude that CISH is an accurate method for determining MYCN gene amplification, with added advantages that make it a more practically useful method.

KW - Chromogenic in situ hybridization

KW - CISH

KW - MYCN

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=19544383792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544383792&partnerID=8YFLogxK

U2 - 10.1097/01.pas.0000149878.78117.ff

DO - 10.1097/01.pas.0000149878.78117.ff

M3 - Article

VL - 14

SP - 72

EP - 76

JO - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 2

ER -